-
321
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
Published 2025-01-01“…To elucidate the central role of lipids in converging multiple pathological aspects of AD, we reviewed the current knowledge on the interplay between lipids and major AD features, including amyloid beta, tau, and neuroinflammation. Finally, we assessed the progresses and obstacles in lipid-based therapeutics and proposed potential strategies for leveraging lipidomics in the treatment of AD.…”
Get full text
Article -
322
The role of glial cells in neuralgia: a bibliometric exploration
Published 2025-02-01“…Keyword analysis highlights research hotspots focusing on glial cell activation, spinal cord injury, satellite glial cells, oxidative stress, and neuroinflammation. The findings suggest that these themes may shape future directions in the field. …”
Get full text
Article -
323
Molecular Mechanisms Underlying Hypothermia-Induced Neuroprotection
Published 2011-01-01“…We proposed that hypothermia contributes to protect neuroinflammation, and identified candidate molecules such as MIP-3α and Hsp70 that warrant further investigation as targets for therapeutic drugs acting as “hypothermia-like neuroprotectants.”…”
Get full text
Article -
324
Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease
Published 2015-01-01“…Furthermore, studies on animal models have shown that TZDs inhibit neuroinflammation, facilitate amyloid-β plaque clearance, enhance mitochondrial function, improve synaptic plasticity, and, more recently, attenuate tau hyperphosphorylation. …”
Get full text
Article -
325
Epigenetic Modulation of Microglia Function and Phenotypes in Neurodegenerative Diseases
Published 2021-01-01“…Microglia-mediated neuroinflammation is one of the most remarkable hallmarks of neurodegenerative diseases (NDDs), including AD, PD, and ALS. …”
Get full text
Article -
326
Profile of STING agonist and inhibitor research: a bibliometric analysis
Published 2025-02-01“…Application of STING agonists primarily focuses on cancer immunotherapy, while STING inhibitors target inflammation, particularly neuroinflammation and acute lung injury.ConclusionCurrent research emphasizes optimizing STING agonists for permeability, efficacy, and safety, with nanotechnology and lipid nanoparticles being prominent delivery techniques. …”
Get full text
Article -
327
Post infectious fatigue and circadian rhythm disruption in long-COVID and other infections: a need for further research
Published 2025-02-01“…This can be driven by various mechanisms including dysregulation of key clock genes (CLOCK, BMAL1, PER2), mitochondrial dysfunction impairing oxidative phosphorylation, and cytokine-induced neuroinflammation (e.g., interleukin-6, tumor necrosis factor-alpha). …”
Get full text
Article -
328
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
Published 2022-01-01“…Therefore, TLR4 may be an important molecular target for treating AD by regulating neuroinflammation. Moreover, TLR4 regulates apoptosis, autophagy, and gut microbiota and is closely related to AD. …”
Get full text
Article -
329
Detection of fungal sequences in human brain: rDNA locus amplification and deep sequencing
Published 2024-12-01“…Abstract The aetiology of Alzheimer’s disease (AD) and Parkinson’s disease (PD) are unknown and tend to manifest at a late stage in life; even though these neurodegenerative diseases are caused by different affected proteins, they are both characterized by neuroinflammation. Links between bacterial and viral infection and AD/PD has been suggested in several studies, however, few have attempted to establish a link between fungal infection and AD/PD. …”
Get full text
Article -
330
Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
Published 2025-01-01“…Abstract Chronic neuroinflammation with sustained microglial activation occurs in Parkinson’s disease (PD), yet the mechanisms and exact contribution of these cells to the neurodegeneration remains poorly understood. …”
Get full text
Article -
331
Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
Published 2025-01-01“…Background: Traumatic brain injury (TBI) is a leading cause of mortality worldwide and often results in substantial cognitive, motor, and psychological impairments, triggering oxidative stress, neuroinflammation, and neurodegeneration. This study examined the neuroprotective effects of azithromycin (AZI) in TBI. …”
Get full text
Article -
332
Glutamatergic CYLD deletion leads to aberrant excitatory activity in the basolateral amygdala: association with enhanced cued fear expression
Published 2025-11-01“…Emerging studies have shown involvement of CYLD in the remodeling of glutamatergic synapses, neuroinflammation, fear memory, and anxiety- and autism-like behaviors. …”
Get full text
Article -
333
The Science of Memory Loss: Insights into Alzheimer’s Disease
Published 2025-02-01“…Emerging therapies, such as monoclonal antibodies targeting amyloid-beta and tau proteins, show promise but are hindered by challenges in efficacy and safety. Neuroinflammation, driven by cytokines like IL-1β and TNF-α, is increasingly recognized as a central contributor to AD pathology, offering new therapeutic targets. …”
Get full text
Article -
334
Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease
Published 2016-01-01“…The present study showed that anxiolytic behavior in cADr is predominantly due to cox-2 mediated neuroinflammation induced neurodegeneration in the brain.…”
Get full text
Article -
335
The Role of Glial Cells in the Pathophysiology of Epilepsy
Published 2025-01-01“…Microglia, the innate immune cells of the CNS, contribute to neuroinflammation, glutamate excitotoxicity, and the balance between excitatory and inhibitory neurotransmission, underscoring their dual role in seizure promotion and protection. …”
Get full text
Article -
336
The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
Published 2024-03-01“…It is important to control neuroinflammation in the central nervous system caused by the pathologic activity of immune cells by considering a high efficacy treatment early in the disease course in order to prevent accumulation of neurological damage and to improve long term outcomes. …”
Get full text
Article -
337
Influence of sleep on seizures and interictal epileptiform discharges in epilepsy
Published 2025-01-01Get full text
Article -
338
The Role of the Immune System in Huntington’s Disease
Published 2013-01-01“…It is still unclear if neuroinflammation is a reactive process or if there is an active influence on disease progression. …”
Get full text
Article -
339
Regulation of pyroptosis by NF-κB signaling
Published 2025-01-01“…Recent studies also indicate that NF-κB modulates the activation of NLRC4 and AIM2 inflammasomes through distinct pathways in diverse inflammatory conditions, such as acute lung injury and neuroinflammation. Additionally, the NF-κB pathway mediates the production of inflammatory cytokines, including IL-1β, IL-33, and TNF-α, which further regulate pyroptosis. …”
Get full text
Article -
340
Fatigue in Parkinson’s disease—A narrative review
Published 2024-12-01“…Emerging evidence suggests that neuroinflammation and autonomic dysfunction may contribute to fatigue. …”
Get full text
Article